Haemonetics Corp. HAE

NYS: HAE | ISIN: US4050241003   30/04/2025
63,02 USD (-1,49%)
(-1,49%)   30/04/2025

31 maart 2025 · Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 · Persbericht

3 maart 2025 · Haemonetics Announces Executive Leadership Updates · Persbericht

15 augustus 2024 · Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System · Persbericht

8 augustus 2024 · Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website · Persbericht

30 juli 2024 · Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire · Persbericht

8 juli 2024 · Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 · Persbericht

18 juni 2024 · Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device · Persbericht

23 mei 2024 · Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes · Persbericht

21 mei 2024 · Haemonetics Announces Proposed Convertible Senior Notes Offering · Persbericht

9 mei 2024 · Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website · Persbericht

10 april 2024 · Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 · Persbericht

4 april 2024 · Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge · Persbericht

1 april 2024 · Haemonetics Corporation Completes Acquisition of Attune Medical · Persbericht

5 maart 2024 · Haemonetics Announces Definitive Agreement to Acquire Attune Medical · Persbericht

21 februari 2024 · Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference · Persbericht

21 februari 2024 · Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day · Persbericht

8 februari 2024 · Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website · Persbericht

11 januari 2024 · Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024 · Persbericht

12 december 2023 · Haemonetics Corporation Completes Acquisition of OpSens Inc. · Persbericht

7 december 2023 · Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference · Persbericht

Mijn selecties